cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Amneal Pharmaceuticals Inc
14 own
22 watching
Current Price
$2.14
$0
(0%)
logo-amrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
649.58M
52-Week High
52-Week High
4.98
52-Week Low
52-Week Low
1.95
Average Volume
Average Volume
0.79M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
84.6746
iconMarket Capitalization649.58M
icon52-Week High4.98
icon52-Week Low1.95
iconAverage Volume0.79M
iconDividend Yield--
iconP/E Ratio84.6746
What does the Amneal Pharmaceuticals Inc do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Amneal Pharmaceuticals Inc make?
News & Events about Amneal Pharmaceuticals Inc.
Globe Newswire
24days ago
ORION CORPORATION PRESS RELEASE 4 JANUARY 2023 at 16.00 EET Orion and Amneal enter strategic partnership Orion receives exclusive licence to commercialise Amneals generic products in Europe, Australia and New Zealand Orion Corporation today announced it has signed a long-term license agreement with ...
Business Wire
24days ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has signed a long-term license agreement with Orion Corporation (OMXH: ORNBV & ORNAV) to commercialize a number of Amneals complex generic products. Under the partnership agreement, Orion is Amneals...
Business Wire
1month ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced that the Company has successfully launched 26 new generic products in 2022. In the fourth quarter of 2022, the Company launched 8 new generic products, including clindamycin phosphate gel 1%, ipratropium bromide nasal...
Business Wire
2 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the Company) today announced that the management team will attend the following investor conferences: Piper Sandler 34th Annual Healthcare Conference December 1, 2022 New York, New York 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 San...
Business Wire
2 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease (PD). IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release...
Frequently Asked Questions
Frequently Asked Questions
What is Amneal Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Amneal Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Amneal Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Amneal Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Amneal Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Amneal Pharmaceuticals Inc?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.14
$0
(0%)
logo-amrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00